110 related articles for article (PubMed ID: 9468580)
1. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1).
Takiyama I; Terashima M; Ikeda K; Kawamura H; Kashiwaba M; Tamura G; Suto T; Nakashima F; Sasaki R; Saito K
Oncol Rep; 1998; 5(2):463-7. PubMed ID: 9468580
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC).
Yano H; Maruiwa M; Iemura A; Mizoguchi A; Kojiro M
Cancer; 1992 Apr; 69(7):1664-73. PubMed ID: 1312890
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue.
Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR
J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.
Saijyo S; Kudo T; Suzuki M; Katayose Y; Shinoda M; Muto T; Fukuhara K; Suzuki T; Matsuno S
Tohoku J Exp Med; 1995 Sep; 177(1):61-71. PubMed ID: 8693487
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model.
Yamada N; Chung YS; Arimoto Y; Sawada T; Seki S; Sowa M
Br J Cancer; 1995 Mar; 71(3):543-8. PubMed ID: 7880737
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma.
Albores-Saavedra J; Chablé-Montero F; Méndez-Sánchez N; Mercado MÁ; Vilatoba-Chapa M; Henson DE
Hum Pathol; 2012 Dec; 43(12):2292-8. PubMed ID: 22795356
[TBL] [Abstract][Full Text] [Related]
7. Critical role of type IV collagens in the growth of bile duct carcinoma. In vivo and in vitro studies.
Chen Y; Satoh T; Sasatomi E; Miyazaki K; Tokunaga O
Pathol Res Pract; 2001; 197(9):585-96. PubMed ID: 11569922
[TBL] [Abstract][Full Text] [Related]
8. Poorly differentiated adenocarcinoma with signet-ring cell carcinoma of the extrahepatic bile duct in a 42-year-old Japanese female: a case report.
Ogata S; Kimura A; Hatsuse K; Yamamoto J; Shimazaki H; Nakanishi K; Kawai T
Acta Med Okayama; 2010 Feb; 64(1):63-5. PubMed ID: 20200586
[TBL] [Abstract][Full Text] [Related]
9. A cholangiocellular carcinoma nude mouse strain showing histologic alteration from adenocarcinoma to squamous cell carcinoma.
Iemura A; Yano H; Mizoguchi A; Kojiro M
Cancer; 1992 Jul; 70(2):415-22. PubMed ID: 1319814
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and characterization of human cholaginocarcinoma, MEC, producing carbohydrate antigen 19-9].
Yoshida K; Tomizawa H; Ota T; Nagashima T; Kikuchi H; Watanabe H; Hashizaki K; Yonaha A
Hum Cell; 1990 Dec; 3(4):346-51. PubMed ID: 1965684
[TBL] [Abstract][Full Text] [Related]
11. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.
Yano H; Iemura A; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M
J Hepatol; 1996 Apr; 24(4):413-22. PubMed ID: 8738727
[TBL] [Abstract][Full Text] [Related]
12. Abnormal distribution of collagen type IV in extrahepatic bile duct carcinoma.
Chen Y; Sasatomi E; Satoh T; Miyazaki K; Tokunaga O
Pathol Int; 2000 Nov; 50(11):884-90. PubMed ID: 11107064
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
[TBL] [Abstract][Full Text] [Related]
14. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
[TBL] [Abstract][Full Text] [Related]
15. Sclerosing adenocarcinoma of the extrahepatic bile duct in a cat.
Pastor J; Majo N; Arbona C; Garcia F; Velarde R; Pumarola M; Lavin S
Vet Rec; 1997 Apr; 140(14):367-8. PubMed ID: 9133721
[TBL] [Abstract][Full Text] [Related]
16. Composite glandular-neuroendocrine carcinoma of the hilar bile duct: report of a case.
Yamamoto J; Abe Y; Nishihara K; Katsumoto F; Takeda S; Abe R; Toyoshima S
Surg Today; 1998; 28(7):758-62. PubMed ID: 9697272
[TBL] [Abstract][Full Text] [Related]
17. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.
Watanabe M; Chigusa M; Takahashi H; Nakamura J; Tanaka H; Ohno T
In Vitro Cell Dev Biol Anim; 2000 Feb; 36(2):104-9. PubMed ID: 10718366
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of human hilar bile duct carcinoma cell line and cell strain.
Jiao W; Yakushiji H; Kitajima Y; Ogawa A; Miyazaki K
J Hepatobiliary Pancreat Surg; 2000; 7(4):417-25. PubMed ID: 11180864
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation.
Nakanishi Y; Kondo S; Hirano S; Ambo Y; Tanaka E; Morikawa T; Itoh T
J Hepatobiliary Pancreat Surg; 2006; 13(4):355-8. PubMed ID: 16858550
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
